October 15, 2024
Ipsen receives its second Shingo Prize for operational excellence
Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patientsIpsen’s…
Pharmaceuticals, Biotechnology and Life Sciences
Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patientsIpsen’s…
TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group” or the “Company”) (CSE: PSYG) hereby announces that…
First Phase 3 PDT study in patients with sBCC in the United States.Rigorous dual endpoints requiring complete clinical and cytological…
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseasesSARASOTA, Fla. and MIAMI, Oct.…
Wa’el Hashad Wa’el Hashad, CEO, Longeveron MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage…
Data selected for oral presentation reinforce previous findings on safety and efficacyMALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) — Neuronetics,…
DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company…
-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with…
EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) — Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results…
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in…